372 related articles for article (PubMed ID: 6981476)
21. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
[TBL] [Abstract][Full Text] [Related]
22. Immune complexes and complement in rheumatoid arthritis.
Lambert PH; Casali P; Nydegger U
Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):301-15. PubMed ID: 534786
[TBL] [Abstract][Full Text] [Related]
23. [Rheumatoid factors, C-reactive protein and circulating immunocomplexes: laser-nephelometric determination using the latex aggregation method. Preliminary evaluation in rheumatoid arthritis].
Bartoloni C; Guidi L; Tricerri A; Baroni R; Pellegrino M; Scrimieri D; Gambassi G
Minerva Med; 1987 Dec; 78(23):1775-8. PubMed ID: 3696453
[TBL] [Abstract][Full Text] [Related]
24. IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.
Westedt ML; Daha MR; de Vries E; Valentijn RM; Cats A
J Rheumatol; 1985 Jun; 12(3):449-55. PubMed ID: 4045842
[TBL] [Abstract][Full Text] [Related]
25. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
26. [Beta2 microglobulin, antibeta2 microglobulin activity and circulating immune complexes in rheumatoid arthritis. Serum and synovial study].
Duquesnoy B; Asfour M; Santoro F; Vandemeulebroucke B; Hochart JP; Delcambre B
Rev Rhum Mal Osteoartic; 1980; 47(7-9):481-7. PubMed ID: 6158754
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica.
Krauledat PB; Krapf FE; Manger B; Kalden JR
Rheumatol Int; 1985; 5(3):97-101. PubMed ID: 3892637
[TBL] [Abstract][Full Text] [Related]
28. Detection and characterization of circulating immune complexes in rheumatoid arthritis.
Wattre P; Santoro F; Bout D; Defrance D; Capron A
Biomedicine; 1976 Sep; 25(7):249-51. PubMed ID: 990384
[TBL] [Abstract][Full Text] [Related]
29. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
Crawhall JC
Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
[TBL] [Abstract][Full Text] [Related]
30. Immune complexes in early arthritis. L Detection of immune complexes before rheumatoid arthritis is definite.
Jones VE; Jacoby RK; Wallington T; Holt P
Clin Exp Immunol; 1981 Jun; 44(3):512-21. PubMed ID: 6976861
[TBL] [Abstract][Full Text] [Related]
31. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
[TBL] [Abstract][Full Text] [Related]
32. The association of cryoglobulinaemia with nodules, vasculitis and fibrosing alveolitis in rheumatoid arthritis and their relationship to serum C1q binding activity and rheumatoid factor.
Erhardt CC; Mumford P; Maini RN
Clin Exp Immunol; 1979 Dec; 38(3):405-13. PubMed ID: 535182
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
34. [Immunologic findings in juvenile Mediterranean kala-azar].
Koletzko B; von Kries R; Wahn V
Monatsschr Kinderheilkd; 1984 Feb; 132(2):96-9. PubMed ID: 6328286
[TBL] [Abstract][Full Text] [Related]
35. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
36. Serum IL-2 level in rheumatoid arthritis: correlation with joint destruction and disease progression.
Tebib JG; Boughaba H; Letroublon MC; Bienvenu J; Noel E; Armanet P; Colson F; Roullet A; Bouvier M
Eur Cytokine Netw; 1991; 2(4):239-43. PubMed ID: 1756229
[TBL] [Abstract][Full Text] [Related]
37. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
[TBL] [Abstract][Full Text] [Related]
38. Anti-globulins and circulating complexes in early rheumatoid arthritis.
Hay FC; Young A; Jones MG; Nineham LJ; Male DK; Roitt IM
Clin Exp Immunol; 1983 Dec; 54(3):723-30. PubMed ID: 6606514
[TBL] [Abstract][Full Text] [Related]
39. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis.
Olmez U; Garred P; Mollnes TE; Harboe M; Berntzen HB; Munthe E
Scand J Rheumatol; 1991; 20(3):183-9. PubMed ID: 2068540
[TBL] [Abstract][Full Text] [Related]
40. Circulating immune complexes and complement in rheumatoid arthritis.
Duquesnoy B
Ann Biol Clin (Paris); 1984; 42(1):71-5. PubMed ID: 6375473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
